$123.11
2.582.14%
al cierre: -
$123.11
0.000.00%
After hour: 4:00 PM EDT
Jazz Pharmaceuticals emite una orientación sobre las ganancias por acción y los ingresos futuros, lo que ofrece a los inversores una idea de cuánto espera ganar la empresa en los próximos períodos.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
08/05/2025 | JAZZ | Jazz Pharmaceuticals | FY | 2025 | $4.80 | $5.60 | $4.94 | $4.15B | $4.30B | $4.23B | |
05/06/2025 | JAZZ | Jazz Pharmaceuticals | FY | 2025 | $20.50 | $22.10 | $4.94 | $4.15B | $4.40B | $4.23B | |
02/25/2025 | JAZZ | Jazz Pharmaceuticals | FY | 2025 | $22.50 | $24.00 | $4.94 | $4.15B | $4.40B | $4.23B | |
01/13/2025 | JAZZ | Jazz Pharmaceuticals | FY | 2024 | — | — | — | $4.00B | $4.10B | $4.32B | |
12/16/2024 | JAZZ | Jazz Pharmaceuticals | FY | 2024 | — | — | — | $4.00B | $4.10B | $4.32B | |
11/06/2024 | JAZZ | Jazz Pharmaceuticals | FY | 2024 | $19.50 | $20.60 | $21.95 | $4.00B | $4.10B | $4.32B | |
07/31/2024 | JAZZ | Jazz Pharmaceuticals | FY | 2024 | $19.20 | $20.30 | $21.95 | $4.00B | $4.10B | $4.32B | |
05/01/2024 | JAZZ | Jazz Pharmaceuticals | FY | 2024 | $18.15 | $19.35 | $21.95 | $4.00B | $4.20B | $4.32B | |
02/28/2024 | JAZZ | Jazz Pharmaceuticals | FY | 2024 | $18.15 | $19.35 | $19.94 | $4.00B | $4.20B | $4.09B | |
01/08/2024 | JAZZ | Jazz Pharmaceuticals | FY | 2023 | — | — | — | $3.81B | $3.81B | $3.83B | |
01/08/2024 | JAZZ | Jazz Pharmaceuticals | FY | 2025 | — | — | — | $5.00B | $5.00B | — | |
11/08/2023 | JAZZ | Jazz Pharmaceuticals | FY | 2023 | $18.15 | $19.00 | $18.66 | $3.75B | $3.88B | $3.83B | |
08/09/2023 | JAZZ | Jazz Pharmaceuticals | FY | 2023 | $18.15 | $19.00 | $17.48 | $3.73B | $3.88B | $3.78B | |
05/10/2023 | JAZZ | Jazz Pharmaceuticals | FY | 2023 | $16.90 | $17.85 | $17.44 | $3.67B | $3.88B | $3.78B | |
03/01/2023 | JAZZ | Jazz Pharmaceuticals | FY | 2023 | $16.90 | $17.85 | $18.00 | $3.67B | $3.88B | $3.76B | |
11/09/2022 | JAZZ | Jazz Pharmaceuticals | FY | 2022 | $17.20 | $17.85 | $17.41 | $3.60B | $3.70B | $3.65B | |
08/03/2022 | JAZZ | Jazz Pharmaceuticals | FY | 2022 | $16.70 | $17.70 | $17.09 | $3.50B | $3.70B | $3.60B | |
05/04/2022 | JAZZ | Jazz Pharmaceuticals | FY | 2022 | — | — | — | $3.50B | $3.70B | $3.58B | |
03/01/2022 | JAZZ | Jazz Pharmaceuticals | FY | 2022 | $16.00 | $17.00 | $17.47 | $3.46B | $3.66B | $3.64B | |
01/10/2022 | JAZZ | Jazz Pharmaceuticals | FY | 2021 | — | — | — | $3.02B | $3.10B | $3.07B | |
11/09/2021 | JAZZ | Jazz Pharmaceuticals | FY | 2021 | $15.10 | $15.80 | $14.52 | $3.02B | $3.10B | $3.09B | |
08/03/2021 | JAZZ | Jazz Pharmaceuticals | FY | 2021 | $13.40 | $14.70 | $14.45 | $3.02B | $3.18B | $3.11B | |
06/17/2021 | JAZZ | Jazz Pharmaceuticals | FY | 2021 | $13.40 | $14.70 | $15.05 | $3.02B | $3.18B | $3.11B | |
05/04/2021 | JAZZ | Jazz Pharmaceuticals | FY | 2021 | $15.65 | $16.86 | $16.39 | $2.55B | $2.70B | $2.65B | |
04/20/2021 | JAZZ | Jazz Pharmaceuticals | Q1 | 2021 | — | — | — | $605.00M | $610.00M | $613.95M | |
02/23/2021 | JAZZ | Jazz Pharmaceuticals | FY | 2021 | $15.65 | $16.85 | $16.78 | $2.55B | $2.70B | $2.56B | |
01/12/2021 | JAZZ | Jazz Pharmaceuticals | FY | 2020 | — | — | — | $2.32B | $2.38B | $2.34B |
La orientación más reciente para Jazz Pharmaceuticals (JAZZ) se informó el agosto 5, 2025 para el año completo 2025. La empresa proporcionó una guía de ganancias por acción en el rango de $4.80 a $5.60, en comparación con el EPS estimado de $4.94. Además, Jazz Pharmaceuticals pronosticó ingresos entre $4.15B y $4.30B para el trimestre.
Explora orientación y previsión sobre todos los valores.